Anbieter: WeBuyBooks, Rossendale, LANCS, Vereinigtes Königreich
EUR 73,39
Anzahl: 1 verfügbar
In den WarenkorbZustand: Good. Most items will be dispatched the same or the next working day. A copy that has been read but remains in clean condition. All of the pages are intact and the cover is intact and the spine may show signs of wear. The book may have minor markings which are not specifically mentioned.
Anbieter: Majestic Books, Hounslow, Vereinigtes Königreich
EUR 90,26
Anzahl: 3 verfügbar
In den WarenkorbZustand: New.
Anbieter: moluna, Greven, Deutschland
EUR 87,54
Anzahl: Mehr als 20 verfügbar
In den WarenkorbZustand: New. Claudio Carini, Sandeep Menon, Mark ChangThe Future of Clinical Research and Health Care: From Empirical to Precision MedicineClinical and Statistical Considerations in Personalized Medicine explores recent advances rela.
Sprache: Englisch
Verlag: Taylor & Francis Ltd Okt 2019, 2019
ISBN 10: 0367378760 ISBN 13: 9780367378769
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Taschenbuch. Zustand: Neu. Neuware.
Anbieter: PBShop.store UK, Fairford, GLOS, Vereinigtes Königreich
EUR 173,78
Anzahl: 1 verfügbar
In den WarenkorbHRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: PBShop.store US, Wood Dale, IL, USA
HRD. Zustand: New. New Book. Shipped from UK. Established seller since 2000.
Anbieter: Revaluation Books, Exeter, Vereinigtes Königreich
EUR 216,68
Anzahl: 1 verfügbar
In den WarenkorbHardcover. Zustand: Brand New. 376 pages. 9.25x6.25x1.00 inches. In Stock.
Anbieter: moluna, Greven, Deutschland
Gebunden. Zustand: New. Claudio Carini, Sandeep Menon, Mark ChangThe Future of Clinical Research and Health Care: From Empirical to Precision MedicineClinical and Statistical Considerations in Personalized Medicine explores recent advances rela.
Anbieter: AHA-BUCH GmbH, Einbeck, Deutschland
Buch. Zustand: Neu. Neuware - Despite the vast amount of literature on biomarkers, there is no comprehensive book that integrates the clinical and statistical components. This book is one of the first to incorporate both the clinical and statistical aspects of biomarkers in the personalized medicine paradigm. Leading clinicians, biostatisticians, regulators, commercial professionals, and researchers address the opportunities and challenges in successfully applying biomarkers in drug discovery and preclinical and clinical development. They cover a wide spectrum of personalized medicine-related topics, including epigenetics, adaptive designs, statistical methods, regulatory issues, and more.